Science-First. US-Made. Compliance-Focused.
P3X Labs was founded to close the gap between peptide research and reliable, transparent supply. We work with licensed American compounding partners to deliver products that meet the expectations of clinicians, researchers, and distributors.
A new standard for peptide supply
P3X Labs was built by scientists, supply-chain specialists, and healthcare operators who saw a need for greater transparency in the peptide market. Too many products traveled through opaque supply chains with inconsistent documentation and unclear origins.
We set out to create a different model: a peptide brand that prioritizes domestic manufacturing, documented quality processes, and direct relationships with licensed compounding professionals. Today, P3X Labs supports a network of physicians, researchers, and distributors who demand reliability from source to vial.
To advance access to high-quality, US-manufactured peptides by partnering with licensed compounding professionals and maintaining rigorous standards for quality, transparency, and compliance.
Precision
Exacting standards in every batch and every process.
Transparency
Clear documentation and open communication at every step.
Partnership
We succeed when our partners succeed.
Compliance
Regulatory rigor is built into our model.
Made in the USA, documented at every step
Our peptides are synthesized, formulated, and finished in US-based facilities. Domestic manufacturing allows us to maintain tighter oversight of raw-material sourcing, environmental controls, and chain-of-custody documentation.
We source starting materials from qualified suppliers, track each batch through production, and retain records to support product integrity and regulatory readiness.
- Domestic synthesis and formulation
- Qualified raw-material suppliers
- Batch records and chain-of-custody documentation
- cGMP-aligned and USP compounding processes
Two pathways, one standard of quality
P3X Labs partners with two categories of licensed compounding facilities to serve different clinical and commercial needs.
503a compounding pharmacies prepare patient-specific prescriptions under a physician's order. These partnerships support individualized therapy and clinical access.
503b outsourcing facilities produce sterile and non-sterile compounded medications in bulk for office use and hospital systems, subject to heightened FDA oversight and cGMP standards. These partnerships support larger-scale, standardized supply.
503a Pharmacy
- Audience
- Patient-specific prescriptions
- Oversight
- State boards of pharmacy and USP chapters
- Use case
- Individualized therapies ordered by licensed practitioners
503b Outsourcing Facility
- Audience
- Clinics, hospitals, and health systems
- Oversight
- FDA registration, cGMP, and USP standards
- Use case
- Standardized bulk supply for professional administration
A Team Built on Compliance and Science
Our leadership combines experience in peptide chemistry, pharmaceutical quality assurance, regulatory strategy, and healthcare operations. We believe that strong partnerships start with clear communication, documented processes, and shared accountability.
Ready to partner with a US peptide supplier you can trust?
Our team is ready to answer your questions and provide the documentation your practice or formulary needs.
Start a conversation